Introduction
Development of high resolution ultrasonography has enabled non-invasive assessment of the structure of vascular walls (1, 2) . Increased intima-media thickness (IMT) of the common carotid artery has been shown to be associated with generalized atherosclerosis (3, 4) . Furthermore, prospective studies have demonstrated that carotid artery wall thickening is associated with an increased risk of myocardial infarction and stroke (5, 6) . Therefore, carotid IMT is considered to be an indicator of generalized, early atherosclerosis (3, 4) . Accordingly, many attempts have been made to determine factors for the progression of carotid IMT, a marker of early atherosclerosis, in a male work site population.
Methods

Study Population
The study population was drawn from the 8,678 male employees of a regional bus and railway company in the Fukuoka area of Japan who attended the annual health examination between 1992 and 1994. Based on the results of the annual health examination, male subjects with ECG abnormalities (arrhythmia or ischemic changes), chest symptoms, hypertension, diabetes mellitus, history of cardiovascular diseases, or healthy volunteers of the employees were invited to the Medical Care Center of the company for further evaluation; the examinations included physical examinations, blood chemistries, exercise ECG, holter ECG and cardiac echocardiography for those suspected of carrying cardiovascular diseases. Of these, 220 randomly selected subjects were again invited to the Medical Care Center for a follow-up examination between 1997 and 1999. Diagnoses of these subjects at the first examination included hypertension, diabetes, minor arrhythmia, and non-specific ST segment and/or T-wave (ST-T) abnormalities. Subjects diagnosed as having myocardial infarction, angina pectoris, hypertrophic cardiomyopathy, or serious arrhythmia at the first examination or during the follow-up period were excluded from the study. The average follow-up period was 62.3 6.5 months. The study protocol was approved by the committee of the Medical Care Center of the company, and informed consent was obtained from each subject.
Blood Pressure and Chemical Measurements
Blood pressure was measured in the right arm of the subjects by physicians using the first and fifth Korotkoff sounds by a standard mercury sphygmomanometer after at least 5 min of rest in the sitting position. Most of the subjects, except those previously diagnosed as having diabetes, underwent a 75 g oral glucose tolerance test (OGTT) after an overnight fasting. Venous blood samples were drawn from the antecubital vein before and 60 and 120 min after the oral glucose loading. Hypertension was defined as systolic blood pressure (SBP) equal to or greater than 140 mmHg and/or diastolic blood pressure (DBP) equal to or greater than 90 mmHg according to the 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension (23) . Those receiving antihypertensive drugs were also defined as hypertensives. Diabetes mellitus was defined by clinical history and/or the results of the 75 g OGTT (fasting plasma glucose equal to or greater than 126 mg/dl and/or plasma glucose 120 min after the oral glucose loading equal to or greater than 200 mg/dl) (24) . Body mass index (BMI) was calculated as weight per height squared.
Assessment of Carotid IMT
IMT of the carotid artery was measured by B-mode ultrasonography using a 7.5 MHz high resolution transducer (SSH-160A; Toshiba Medical Co., Ltd., Tokyo, Japan) with the subject in a supine position. Longitudinal B-mode scannings were performed by a single trained technician, and longitudinal images were digitized and stored on an optical disk. Measurements of the IMT were made by using an automated edge-detection algorithm (Picture Measurement; Whiterock Co., Ltd.) at the far wall of the common carotid artery at sites 1 to 3 cm proximal to the carotid bifurcation. IMT of the far wall was measured as the distance from the leading edge of the first echogenic line to the leading edge of the second echogenic line. IMT was measured at three points on each side of the carotid artery, and the maximal values were used for statistical analysis. Lesions that consisted of apparent plaques were excluded from the measurement. A plaque was defined as a distinct area with either mineralization or focal protrusion into the lumen (5, 10) . The reproducibility of the measurement was tested by scanning 1 week later in randomly selected subjects. The correlation between the maximal IMT in the first scanning and second scanning was 0.983 ( p 0.0001).
Smoking and Alcohol Intake
Cigarette smoking and alcohol intakes were ascertained individually by an interview with public health nurses. Smokers and non-smokers were categorized and coded as follows: 1, non-smokers (never smoked); 2, past smokers (quit more than 5 years ago); 3, past smokers (quit within 5 years); 4, smokers of 1-10 cigarettes/day; 5, smokers of 11-20 cigarettes/day; 6, smokers of 21 cigarettes/day. Alcohol intake was classified as follows by the use of a traditional Japanese unit, the "gou" (1 gou is equivalent to 180 ml; a gou of Japanese wine contains 22.7 g ethanol ): 1, non drinker; 2, 1-7 gous Japanese wine/week; 3, 8-14 gous/week; 4, 14 gous/week.
Statistical Analysis
The values are expressed as the mean SD. Analyses, including unpaired Student's t test, univariate analysis, and multiple linear regression analysis were performed with the use of the Statistical Analysis System (SAS, SAS Institute Inc., Cary, USA). Values of p 0.05 were considered to indicate statistical significance.
Results
Characteristics of the study subjects are shown in Table 1 . The average value of the maximal IMT of the common carotid artery at the baseline examination was 0.669 0.136 mm. In a multivariate regression analysis in which baseline age, DBP, BMI, total cholesterol, high density lipoprotein (HDL) cholesterol and HbA1c were entered as independent variables, the baseline maximal carotid IMT was positively associated with age, DBP and total cholesterol level, and negatively with HDL cholesterol level ( Table 2) . When baseline SBP, in place of DBP, was entered into this analysis, SBP also tended to be associated with baseline IMT, but this relationship did not reach the level of statistical significance ( p 0.062). In a separate analysis, the carotid IMT also tended to be positively associated with smoking habit ( p 0.083), albeit not significantly so. The maximal IMT of the carotid artery increased from 0.669 0.135 mm to 0.784 0.229 mm after an average of 62.3 6.5 months of follow-up, yielding an annual progression rate of 0.023 0.003 mm/year. In a subclass analysis in diabetic (n 65) and non-diabetic subjects (n 155), the rate of increase in the maximal carotid IMT was 0.023 0.004 mm/year for diabetes, and 0.023 0.003 mm/year for non-diabetics, which did not differ between the two groups.
In univariate analysis, the progression rate of the carotid IMT was positively associated only with total cholesterol (Table 3) . In multivariate regression analysis, when baseline IMT, age, DBP, BMI, total cholesterol, HDL cholesterol and HbA1c were entered as independent variables, the progression rate of the carotid IMT was positively associated only with the total cholesterol level (Table 4) . Age tended to be associated with the progression of IMT, but this relationship did not reach the level of statistical significance ( p 0.06). When low density lipoprotein (LDL) cholesterol calculated using Friedewald equation (25) was entered into the analysis, in place of total cholesterol, LDL cholesterol was found to be the only independent determinant of the progression rate of the carotid IMT (partial regression coefficient 0.000237; p 0.0012). As shown in Fig. 1 , the association between baseline total cholesterol levels and the progression of the carotid IMT appeared to be linear with no obvious threshold level of total cholesterol for the increase of the carotid IMT. When we excluded from the analysis those subjects who received antihypertensive drugs, oral glucose-lowering The abbreviations are the same as Table 1 . Table 2. drugs, or lipid-lowering drugs at any time during the study period, total cholesterol level remained as a significant independent variable for the progression of carotid IMT (partial regression coefficient 0.00018; p 0.0245; n 160).
Relationships between the changes of the clinical variables before and after the follow-up period and the progression rate of the carotid IMT were also analyzed ( Table 5) ; none of the changes of these variables was associated with the progression of the carotid IMT in a univariate analysis.
Discussion
The present study demonstrated that the progression of carotid IMT over 5 years in male subjects in a Japanese work-site population was positively associated with the baseline level of total cholesterol, although the baseline carotid IMT was positively associated with age, DBP, and total cholesterol, and negatively with HDL. These findings suggest that the total cholesterol level may be one of the most important predictors of the progression of early atherosclerosis in middle-aged Japanese men, and emphasize the importance of controlling cholesterol levels in order to prevent the progression of early atherosclerosis.
In the present study, baseline carotid IMT was associated positively with established cardiovascular risk factors, such as age, blood pressure, and total cholesterol, and inversely with HDL cholesterol. Baseline IMT also tended to be positively associated with current cigarette smoking. These strong associations between carotid IMT and established cardiovascular risk factors may indicate that the IMT measured in this study could be used as a valid marker of early atherosclerosis.
In the present study, among several risk factors, only the total cholesterol level was detected as a significant positive variable for the progression of carotid IMT in a multivariate analysis, suggesting that the total cholesterol level may be one of the strongest determinants of the progression of carotid IMT in our study population. Although the importance of total cholesterol as a risk factor for cardiovascular diseases, especially coronary artery diseases, is well established (26) , the present findings suggest that the total cholesterol level also plays an important role in the progression of early atherosclerosis. It appears likely that the LDL cholesterol level played a pivotal role for the progression of IMT, since the calculated value of LDL cholesterol (25) in this study was also significantly associated with the progression of IMT, while neither triglyceride nor HDL cholesterol was associated with the progression of IMT.
Although there have been several studies investigating risk factors for the progression of carotid IMT, their results have been inconsistent, and various factors, such as SBP, pulse pressure, obesity, smoking habits, and psychological stress, have been reported to be associated with the progression of IMT (20) (21) (22) (27) (28) (29) . However, only a few studies have detected total cholesterol (or LDL cholesterol) as a risk factor for the progression of IMT (20) . The reason for such diverse findings is unclear, but the difference may arise, at least in part, from differences in the study population and/or the study design. Salonen and Salonen (20) have demonstrated that in a Finish male population serum LDL cholesterol, age, pack-years of smoking, blood leukocyte count, and platelet aggregability were independently associated with the progression of carotid IMT over 2 years. In their study, neither blood pressure nor HDL cholesterol was associated with the IMT progression. Our findings extend previous studies in Western populations by showing for the first time an association between the total cholesterol level and the progression of carotid IMT in an Eastern (Japanese) population, in which the prevalence of atherosclerotic lesions in the extracranial carotid arteries has been reported to be lower than in Western populations (30) .
Recent intervention studies have consistently demonstrated that cholesterol-lowering therapy with 3-hydroxy-3- The abbreviations are the same as Table 1 . methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) reduced the progression of carotid IMT in subjects with elevated total or LDL cholesterol levels (31) (32) (33) . These findings may provide indirect support for the importance of total cholesterol as a risk factor for the progression of carotid IMT, although the possible contribution of pleiotropic effects of statins (34)-independent of their cholesterol-lowering effects-to these observations cannot be totally dismissed. In this study, total cholesterol levels were below 250 mg/dl in the majority of the study subjects, and the average value of total cholesterol was similar to, or just above, the average value of the Japanese general population (35) . However, the total cholesterol level appeared to exhibit continuous association with the progression of carotid IMT without an apparent threshold level, suggesting that total cholesterol even within the normal range might play a role in the progression of early atherosclerosis. Similarly, in a study by Salonen and Salonen (20) , the carotid IMT increased linearly above LDL cholesterol levels of 3.0 mmol/l. Consistent with these findings, in patients with coronary artery disease and average or below-average cholesterol levels, treatment with the HMG-CoA reductase inhibitor pravastatin reduced the increase in carotid IMT over 4 years of follow-up (36) .
Age is considered to be one of the strongest determinants of the carotid IMT (7-12, 14, 15) , and age was indeed associated with the baseline IMT in this study. Baseline age also tended to be associated with the progression of IMT, but this relationship did not reach the level of statistical significance ( p 0.06), probably because of the narrow range of age distribution in this study population, i.e., the majority of the study subjects were in their late 40s or 50s.
Yamasaki et al. (37) demonstrated that in Japanese diabetic patients, baseline and average follow-up levels of HbA1c were associated with the progression of carotid IMT. In this study, although baseline carotid IMT tended to be associated with HbA1c ( p 0.089), the progression rate of carotid IMT did not differ between diabetics and non-diabetics, and it was not related to the level of HbA1c. The difference in results between our study and that of Yamasaki et al. (37) might have arisen from differences in the severity of diabetes; i.e., the HbA1c level at the baseline examination was 5.92% in total subjects and 7.16% even in diabetic subjects in this study, whereas it was 8.66% in their study. Indeed, in the Insulin Resistance Atherosclerosis Study (38) , the increased carotid wall thickness was associated with established diabetes but not with impaired glucose tolerance. On the other hand, in our previous cross-sectional study, both insulin resistance and hyperinsulinemia were associated with carotid IMT in normotensive subjects drawn from the same occupational population (14) . Further studies will be needed to determine whether or not mild diabetes or impaired glucose tolerance would promote the progression of early atherosclerosis.
In some but not all previous studies, blood pressure (21, 22) or pulse pressure (22) was detected as a significant determinant of carotid IMT progression. In the present study, blood pressure were associated with the baseline carotid IMT but not with the progression of IMT. The reason for this discrepancy among the studies is unclear. The narrow distribution of blood pressure in this study, since most of the study subjects were normotensive, might have masked the influence of blood pressure on the progression of IMT. Alternatively, the duration of follow-up may not have been long enough to detect the influence of blood pressure, or the influence of blood pressure on the progression of IMT might indeed have been of minor importance in our study population.
The present study has several limitations. First, we included mainly middle-aged male subjects in this study, and thus it remains to be determined whether the present findings are applicable to female populations or older subjects. Second, the sample size of this study may not have been large enough to fully detect risk factors for the progression of IMT. Third, the degree of risk factors may change during the follow-up period, and the baseline values might not necessarily represent the value of the whole follow-up period. In fact, however, none of the changes of the variables during the follow-up period was associated with the progression of the carotid IMT.
In conclusion, although age, blood pressure, total cholesterol and HDL cholesterol were associated with carotid IMT in a cross-sectional analysis, only the total cholesterol level was associated with the progression of carotid IMT in a Japanese male working population. It thus appears that total cholesterol played an important role in the progression of early atherosclerosis in our study population, a result which underscores the importance of maintaining lower cholesterol levels in order to prevent the progression of atherosclerosis in a middle-aged, male working population.
